Principal Investigator
Terrence Bradley
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20211051
Clinical Trial Summary
Phase 1/1b Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat and in Combination with Ruxolitinib in Patients with Myelofibrosis.
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Leukemia
Contact Information
Phone Number
305-243-2647